Search
Policy & advocacy
Our mandateEHA’s policy and advocacy work is guided by the European Affairs Committee, which sets the priorities, formulates positions and actively contributes to engagement with policy makers and stakeholders.
Read moreChallenges and opportunities in the diagnostics and management of onco-hematological patients under the microscope during tutorial in Russia
Onco-hematology was the focus of the two-day EHA Hematology Tutorial in Moscow, Russia, the third joint tutorial organized by EHA, the National Hematological Society (NHS) and the Russian-Oncohematology Society (ROHS).
Read moreHighlights of Past EHA (HOPE) MENA 2021
For the upcoming edition of the Highlights of Past EHA (HOPE) Middle East and North Africa (MENA), EHA will organize a truly regional meeting by collaborating simultaneously with our hematology partners from the region.
Read moreIVDR
As of May 26, 2022, the new EU In Vitro Diagnostic medical devices Regulation (IVDR) comes into effect.
Read moreEHA Statement of Solidarity with Ukraine
The European Hematology Association (EHA) is deeply concerned about the situation in Ukraine, the plight of the civilian population, and the damage to healthcare infrastructures.
Read moreEHA-SWG Scientific Meeting on Patient-centered Geriatric Hematology - report
Live sessions: October 6-7, 2021
Chairs: Prof R Cordoba (Spain) and Dr V Goede (Germany)
An international group of hematologists, specialist nurses, patient advocates, geriatricians, basic research, and pharma representatives gathered digitally to participate in this meeting.